Asusi, Gwendoline .
HRN: 26-26-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2024
AMPICILLIN 1GM (VIAL)
11/30/2024
12/06/2024
IV
2 G
Q6
T/c Endometritis
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes